X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8864) 8864
Publication (746) 746
Book Review (59) 59
Book Chapter (50) 50
Conference Proceeding (31) 31
Book / eBook (21) 21
Magazine Article (11) 11
Dissertation (3) 3
Paper (2) 2
Newsletter (1) 1
Streaming Video (1) 1
Trade Publication Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (7247) 7247
female (5173) 5173
male (4590) 4590
index medicus (4421) 4421
middle aged (3605) 3605
absorptiometry, photon (3013) 3013
aged (2818) 2818
adult (2562) 2562
tomography, emission-computed, single-photon (1928) 1928
radiology, nuclear medicine & medical imaging (1553) 1553
osteoporosis (1415) 1415
bone density (1377) 1377
risk factors (1293) 1293
medicine & public health (1147) 1147
endocrinology & metabolism (1135) 1135
treatment outcome (930) 930
animals (918) 918
bone density - drug effects (918) 918
aged, 80 and over (887) 887
cardiac & cardiovascular systems (874) 874
adolescent (869) 869
oncology (846) 846
density (830) 830
bones (772) 772
bone mineral density (762) 762
prospective studies (736) 736
child (727) 727
orthopedics (723) 723
tomography, emission-computed, single-photon - methods (722) 722
photons (720) 720
follow-up studies (704) 704
time factors (701) 701
women (688) 688
cardiology (685) 685
analysis (670) 670
health aspects (664) 664
research (662) 662
risk (661) 661
care and treatment (654) 654
radiotherapy (653) 653
nuclear medicine (597) 597
magnetic resonance imaging (579) 579
body mass index (577) 577
cancer (573) 573
tomography, x-ray computed (558) 558
therapy (557) 557
spect (554) 554
diagnosis (552) 552
surgery (550) 550
body composition (549) 549
bone density - physiology (549) 549
retrospective studies (547) 547
young adult (526) 526
imaging / radiology (521) 521
fractures (520) 520
mineral density (517) 517
postmenopausal women (516) 516
cross-sectional studies (512) 512
tomography (489) 489
clinical neurology (481) 481
radiopharmaceuticals (477) 477
prognosis (476) 476
physiological aspects (475) 475
single photon emission computed tomography (466) 466
children (462) 462
absorptiometry, photon - methods (456) 456
spect imaging (451) 451
patients (445) 445
article (432) 432
medical imaging (421) 421
sensitivity and specificity (418) 418
risk assessment (404) 404
exercise (400) 400
radiotherapy dosage (400) 400
predictive value of tests (394) 394
mass (392) 392
bone-mineral density (386) 386
obesity (385) 385
x-ray absorptiometry (376) 376
rheumatology (374) 374
prevalence (371) 371
disease (366) 366
radiation (356) 356
reproducibility of results (353) 353
computed tomography (351) 351
nutrition & dietetics (343) 343
endocrinology (340) 340
usage (340) 340
medicine (338) 338
osteoporosis - etiology (334) 334
metabolism (332) 332
photon (330) 330
neurosciences (329) 329
mortality (323) 323
men (322) 322
pediatrics (318) 318
abridged index medicus (316) 316
child, preschool (315) 315
rats (315) 315
double-blind method (309) 309
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8678) 8678
Japanese (83) 83
German (59) 59
French (43) 43
Russian (40) 40
Spanish (24) 24
Chinese (17) 17
Italian (12) 12
Polish (11) 11
Danish (9) 9
Hungarian (8) 8
Portuguese (5) 5
Czech (2) 2
Dutch (2) 2
Korean (2) 2
Lithuanian (2) 2
Norwegian (2) 2
Turkish (2) 2
Corsican (1) 1
Croatian (1) 1
Hebrew (1) 1
Romanian (1) 1
Serbian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Journal of Infectious Diseases, ISSN 0022-1899, 6/2011, Volume 203, Issue 12, pp. 1791 - 1801
Background. Long-term effects of abacavir (ABC)-lamivudine (3TC), compared with tenofovir (TDF)-emtricitabine (FTC) with efavirenz (EFV) or atazanavir plus... 
HIV/AIDS | Percentage change | RNA | Spine | Bones | Bone density | Arm | Hip | Bone fractures | HIV 1 | Arts | INFECTIOUS DISEASES | EFFICACY | INITIATION | MICROBIOLOGY | PREVALENCE | IMMUNOLOGY | COMBINATION | OSTEOPOROSIS | HIV-INFECTED PATIENTS | WOMEN | THERAPY | COHORT | HEALTH | Humans | Middle Aged | Antiretroviral Therapy, Highly Active - adverse effects | Fractures, Bone - epidemiology | Male | Oligopeptides - adverse effects | Viral Load | Lamivudine - adverse effects | Tenofovir | Pyridines - adverse effects | Adenine - adverse effects | Ritonavir - adverse effects | Atazanavir Sulfate | Adult | Deoxycytidine - adverse effects | Female | Dideoxynucleosides - adverse effects | Drug Therapy, Combination | Emtricitabine | Adenine - analogs & derivatives | Osteoporosis - chemically induced | Anti-HIV Agents - adverse effects | Risk Factors | Organophosphonates - adverse effects | Benzoxazines - adverse effects | CD4 Lymphocyte Count | Absorptiometry, Photon | Bone Density - drug effects | HIV Infections - complications | Intention to Treat Analysis | HIV Infections - drug therapy | Fractures, Bone - chemically induced | Deoxycytidine - analogs & derivatives | Drug Combinations | Usage | Care and treatment | Ritonavir | Drug utilization | Lamivudine | Efavirenz | Prevention | Abacavir | Dosage and administration | Drug therapy, Combination | Drug therapy | HIV infection | Major and Brief Reports
Journal Article
Journal Article
Journal of Nuclear Cardiology, ISSN 1071-3581, 6/2014, Volume 21, Issue 3, pp. 563 - 569
Intravenous administration of aminophylline is widely adopted to reverse dipyridamole-related adverse effects (AEs) during stress myocardial perfusion imaging... 
pharmacologic stress | Medicine & Public Health | adverse effect | aminophylline | Dipyridamole | Nuclear Medicine | myocardial perfusion imaging: SPECT | Cardiology | Imaging / Radiology | CORONARY-ARTERY DISEASE | CARDIAC & CARDIOVASCULAR SYSTEMS | SAFETY | TOXICITY | THEOPHYLLINE | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Injections, Intravenous | Prevalence | Humans | Middle Aged | Male | Incidence | Dose-Response Relationship, Drug | Young Adult | Drug Interactions | Aged, 80 and over | Dipyridamole - adverse effects | Adult | Female | Retrospective Studies | Radiopharmaceuticals | Thallium Radioisotopes | Aminophylline - administration & dosage | Comorbidity | Risk Factors | Exercise Test - statistics & numerical data | Treatment Outcome | Drug-Related Side Effects and Adverse Reactions - epidemiology | Exercise Test - adverse effects | Coronary Artery Disease - diagnostic imaging | Cardiotonic Agents - administration & dosage | Myocardial Perfusion Imaging - adverse effects | Aged | Coronary Artery Disease - epidemiology | Vasodilator Agents - adverse effects | Myocardial Perfusion Imaging - statistics & numerical data | Tomography, Emission-Computed, Single-Photon - adverse effects | Tomography, Emission-Computed, Single-Photon - statistics & numerical data | Complications and side effects | Dosage and administration | SPECT imaging | Cardiac patients | Aminophylline
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 10/2010, Volume 51, Issue 8, pp. 963 - 972
Journal Article
Journal Article
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 10/2011, Volume 53, Issue 8, pp. 807 - 816
Background. We compared 3 years of antiretroviral therapy with raltegravir or efavirenz as part of a combination regimen in the ongoing STARTMRK study of... 
HIV/AIDS | Antiretrovirals | Fasting | HIV | Body fat | Response rates | Viruses | Lipids | Fats | Virology | HIV 1 | INFECTIOUS DISEASES | RESISTANT HIV-1 INFECTION | MULTICENTER | EFFICACY | SAFETY | MICROBIOLOGY | HIV-1-INFECTED PATIENTS | RANDOMIZED CONTROLLED-TRIAL | IMMUNOLOGY | THERAPY | DOUBLE-BLIND | LOPINAVIR/RITONAVIR | SUBGROUP | Humans | Male | RNA, Viral - blood | Viral Load | Anti-HIV Agents - administration & dosage | Pyrrolidinones - administration & dosage | Tenofovir | Adenine - adverse effects | HIV-1 - isolation & purification | Adult | Deoxycytidine - adverse effects | Female | Drug Therapy, Combination | Raltegravir Potassium | Emtricitabine | Pyrrolidinones - adverse effects | Adenine - analogs & derivatives | Benzoxazines - administration & dosage | Double-Blind Method | Drug Administration Schedule | HIV-1 - drug effects | Anti-HIV Agents - adverse effects | Deoxycytidine - administration & dosage | HIV Infections - virology | Organophosphonates - adverse effects | Benzoxazines - adverse effects | Treatment Outcome | CD4 Lymphocyte Count | Absorptiometry, Photon | Adenine - administration & dosage | Organophosphonates - administration & dosage | Adolescent | HIV Infections - drug therapy | Deoxycytidine - analogs & derivatives | Usage | Drug utilization | HIV patients | Dosage and administration | Drug therapy, Combination | Drug therapy | Efavirenz | Raltegravir
Journal Article
Neurologia medico-chirurgica, ISSN 0470-8105, 2011, Volume 51, Issue 7, pp. 479 - 483
Journal Article
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 1, pp. 108 - 116
Journal Article